Sofosbuvir-based regimens for HCV in stage 4-stage 5 chronic kidney disease. A systematic review with meta-analysis

By sjmartinez • September 28, 2022

Fabrizi F, Cerutti R, Dixit V, Ridruejo E. Sofosbuvir-based regimens for HCV in stage 4-stage 5 chronic kidney disease. A systematic review with meta-analysis. Nefrologia (Engl Ed). 2021 Sep-Oct;41(5):578-589. doi: 10.1016/j.nefroe.2021.11.011. PMID: 36165141.

Tags: Acontecimientos adversos, Adverse events, Antivíricos de acción directa, Diálisis, dialysis, Digestive Diseases, Direct-acting antivirals, Hepatitis C, Publications, Respuesta virológica, Sofosbuvir

COMPUTER-AIDED DIAGNOSIS IMPROVES CHARACTERIZATION OF BARRETT’S NEOPLASIA BY GENERAL ENDOSCOPISTS

Jukema JB, Kusters CHJ, Jong MR, Fockens KN, Boers T, van der Putten JA, Pouw RE, Duits LC, Weusten BAM, Herrero LA, Houben MHMG, Nagengast[...]

Ambient long-term exposure to organophosphorus pesticides and the human gut microbiome: an observational study

Zhang K, Paul K, Jacobs JP, Cockburn MG, Bronstein JM, Del Rosario I, Ritz B. Ambient long-term exposure to organophosphorus pesticides and the human gut[...]

Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults

Patel SG, May FP, Anderson JC, Burke CA, Dominitz JA, Gross SA, Jacobson BC, Shaukat A, Robertson DJ. Screening for Colorectal Cancer in Asymptomatic Average-Risk[...]